Pharmaceutical industry – Page 5
-
OpinionWelcome to the MegaPharm target selection and project resourcing meeting
Overheard recently in a seminar room near you…
-
OpinionWeight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
-
BusinessEnding of US weight-loss drug shortages prompts compounder complaints
Decision ends pharmacies’ permission to prepare versions of GLP-1 hormone mimics
-
OpinionWhy companies are rushing to flatter Trump
Pharma firms are among many pausing diversity programmes and promising domestic investment
-
BusinessNew Trump tariffs worry North American chemical industries
High duties on imports from Canada, Mexico and China raise problems for international supply chains
-
OpinionFluorine makes you an offer you can’t refuse
What might we do if we had a new, electron-donating equivalent element?
-
ResearchGenerative AI pipeline creates promising antimicrobial peptides
AI model extrapolates beyond training data to predict diverse antimicrobial structures
-
BusinessNew type of painkiller approved in US
Sodium channel blocker prevents nerves transmitting pain signals
-
FeaturePutting the F in pharma
Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame the ninth element
-
ResearchFar more drugs could be taken orally by formulating them with silica nanoparticles
Many more medicines could be made water soluble making taking them easier for patients
-
BusinessNew Purdue bankruptcy deal cuts out Sacklers’ legal immunity
$7.4 billion proposal will fund support for victims of US opioid crisis
-
BusinessJ&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
-
OpinionSharing the burden of contraception could also mean sharing the risk
What if risk assessments for contraception considered the sum of risk to both members of a couple?
-
FeatureOn the trail of the male contraceptive pill
As multiple novel male contraception compounds enter clinical trials, is family planning about to undergo a second revolution? James Mitchell Crow reports
-
OpinionRobots queuing up to fail
Claims of an AI revolution in drug discovery are missing the biggest problem
-
BusinessAthira pharma settles research misconduct charges for $4 million
Deal with US Department of Justice resolves allegations against former chief executive
-
FeatureThe promise of drugs that send proteins to the shredder
Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to strategic discovery
-
WebinarHarnessing hormones for health: Taking GLP-1 from research to reality
Learn about the groundbreaking science research behind the GLP-1 revolution
-
BusinessPharmaceuticals roundup 2024
Diabetes and weight loss drugs have surged in popularity, revealing supply frailties
-
